Stock Events

Stock Events

Protalix BioTherapeutics (PBDA.F) Q2 2025 Earnings

9MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.04

0

0.05

0.09

Details

Expected EPS

0.0710824

Actual EPS

-0.04442650000000001

Surprise EPS

-0.12

Surprise Percent

+162.5%

Description

Protalix BioTherapeutics (PBDA.F) has reported earnings of -0.04442650000000001 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.